Urologic Oncology Section

Similar documents
Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up

Friday 25 May EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)

Highlighting Clinical Trials Muscle Invasive Bladder Cancer

Mayo Clinic Update in Urology 2017: February 20-24, 2017 Atlantis, Paradise Island Bahamas

PRACTICAL Urology. USC Institute of Urology 4 th Annual Conference: Guest Faculty. Thursday January 31, January 31, February 1 2, 2019

Saturday, 13 February 2016

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Appendix 4 Urology Care Pathways

Cystectomies and bladder preservation: What you need to know

Outcomes. Glickman Urological & Kidney Institute

International Journal of Health Sciences and Research ISSN:

Steamboat Springs, Colorado. January 15-18, 2016

Chemotherapy Treatment Algorithms for Urology Cancer

International London Uropathology Conference 2014

Activity Report July 2012 June 2013

ESOU programme Prostate cancer screening: Why screening programme should not be adopted in > 65 A. Heidenreich, Aachen (DE)

FRIDAY, DECEMBER 14, 2018

Open clinical uro-oncology trials in Canada

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Open clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD

Subject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49

6 TH INTERNATIONAL TECHNO-UROLOGY MEETING (TUM) NEW TECHNOLOGIES FOR A MORE PRECISE SURGERY

Open clinical uro-oncology trials in Canada

Trimodality Therapy for Muscle Invasive Bladder Cancer

PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018

Open clinical uro-oncology trials in Canada

Index. Note: Page numbers of article titles are in boldface type.

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

DEPARTMENT OF ONCOLOGY ELECTIVE

Open clinical uro-oncology trials in Canada

CLINICAL TRIALS Open clinical uro-oncology trials in Canada George Rodrigues, MD, Eric Winquist, MD

Open clinical uro-oncology trials in Canada

Asian Urology Residents' Course 2018 Program

Asian Urology Residency Course 2017 (AURC 2017)

PAUL PETERS 2018 PROGRAM. 9:20am Reconstructive Urology Case Discussion Maxim McKibben MD, Joceline Fuchs MD, Allen Morey MD (moderator)

Urology An introduction to cut up DR J R GOEPEL

ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain

PROGRAMME DRAFT. September 18 th to 20 th 2008

NICaN Testicular Germ Cell Tumours SACT protocols

44 th Annual Northern California Urological Resident Seminar

Pathology Driving Decisions

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

A schematic of the rectal probe in contact with the prostate is show in this diagram.

Bladder Cancer Guidelines

IMMUNE CHECKPOINT THERAPY FOR GENITOURINARY CANCERS: KIDNEY CANCER AND TRANSITIONAL CELL CARCINOMA

UROLOGICAL CANCER 2010 COMPARATIVE AUDIT REPORT

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

Open clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD

Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer

UROLOGY CANCER 2009 COMPARATIVE AUDIT REPORT

Part II: Treatment. A Woman-to-Woman Talk with Dr. Armine Smith. Wednesday, March 8, Presented by

National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trial design:

FRIDAY, DECEMBER 14, 2018

The European Board of Urology

The Use of PET Scanning in Urologic Oncology

A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy

Programme - Wednesday, 5 September

MARK S. SHIMKO, M.D. Chesapeake Urology Associates, LLC

ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY

High risk non-muscle invasive bladder cancer: From guidelines to future approaches Chairs: A. Lopez Beltran, Lisbon (PT)

Commissioning Urology Services in New NHS

Atlas of Urologic Surgery

Urological Tumours 1 Kidney tumours 2 Bladder tumours

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Causes of Raised PSA A very large prostate Gland Infection of urine or Prostate Gland Possibility of prostate Cancer

Radical Cystectomy Often Too Late? Yes, But...

Genitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General

When to Integrate Surgery for Metatstatic Urothelial Cancers

Minimally Invasive Prostate Surgery Department of Urology, Centro Hospitalar do Porto presents:

ECC or Margins Positive?

MEDitorial March Bladder Cancer

Treatment Testicular Cancer Guidelines

UNM SRMC UROLOGY CLINICAL PRIVILEGES.

Bladder replacement in men and women: when and when not? Outline. Continent Diversion History

NICE BULLETIN Diagnosis & treatment of prostate cancer

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

Partial Cystectomy for Invasive Bladder Cancer

Loma Linda University Children s Hospital Loma Linda, CA UROLOGY PRIVILEGE FORM

January 10-12, Westin Harbour Castle Toronto, ON #CUOS19. cuos2019.org

Minimally invasive surgery in urology oncology. Dr. Tongchai Nakamont 23 Jan 2014

UK CAA Oncology Certification Charts

DIPLOMA IN GYNECOLOGICAL ENDOSCOPY TRAINING (MIS 1 & MIS 2) 13TH 17TH March, 2019

Case 1. Receives induction BCG weekly x 6 without significant toxicity Next step should be:

in Laparoscopy The European Congress of Laparoscopy 2007 Bordeaux, France Palais des Congres

AUA Guidelines for Invasive Bladder Cancer: What s New?

Optimising Prostate Cancer Diagnostics

FOLLOW-UP STRATEGIES AND MANAGEMENT OF RECURRENCE IN UROLOGIC ONCOLOGY. Preface Dan Theodorescu

Index. Note: Page numbers of article titles are in boldface type.

Objectives. Target Audience. Accreditation. Course Description

GUIDELINES ON TESTICULAR CANCER

Preliminary Programme

Testicular Cancer. Regional Follow-up Guidelines

da Vinci Prostatectomy My Greek personal experience

Scientific Program Schedule AMA PRA Category 1 Credits

COURSES ENDORSEMENT AND ACCREDITATION

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

Transcription:

in Gynecologic and Oncology 08:00 09:00 Registration Day 1 27 April, 2017 Thursday 09:00 09:15 Welcome Oleg Sukonko, Edward Trimble 09:15 12:00 Live surgery 1 Laparoscopiс Radical Prostatectomy 13:00 15:00 Live surgery 2 Laparoscopic Radical Prostatectomy 15:00 15:30 Coffee break 15:30 15:50 Laparoscopic Radical Prostatectomy in the Era of RALP 15:50 16:10 Lymph Node Dissection During Radical Prostatectomy: When and How Avi Beri 16:10 16:30 Surgical Anatomy of Laparoscopic Radical Prostatectomy in Relation to Urinary Continence and Potency 16:30 16:50 Management of Complications of Laparoscopic Prostatectomy Sergey Popov 16:50 17:10 Laparoscopic Experience in Georgia David Nikoleishvili 17:10 17:30 Training of al Laparoscopy in Ukraine: Achievements and Current Problems Nikolai Sosnin 17:30 18:00 Perioperative Management of Surgical Patients Alexander Minich 1/5

in Gynecologic and Oncology Day 2 09:00 09:15 Epidemiology of Genitourinary Cancer in Belarus Alesia Evmenenko 09:15 09:25 Testicular Cancer Problem: What It s All About? 28 April, 2017 Friday 09:25 12:00 Session 1: Prostate cancer 09:25 09:40 Prostate Cancer Screening in 2017: Public Health Approach Vitaly Smelov 09:40 10:00 Prostate Cancer Screening in 2017: The Urologist s Approach 10:00 10:20 Diagnosis of Prostate Cancer: Current Status and Future Perspectives Gennady Bratslavsky 10:20 10:30 Q&A / PCa Diagnosis 10:30 10:50 Active Surveillance in Prostate Cancer: Whom and How? 10:50 11:10 Radical Prostatectomy in Prostate Cancer Treatment 11:10 11:30 High-Risk Prostate Cancer: The Role of Surgery in Multimodal Treatment 11:30 11:50 Metastatic Prostate Cancer: From Hormone Sensitive to Castration Resistance 11:50 12:00 Q&A / PCa Treatment 2/5

in Gynecologic and Oncology 13:00 14:00 Session 2: Renal cancer Day 2 13:00 13:20 Small Renal Mass: Biopsy and Active Surveillance Gennady Bratslavsky 13:20 13:40 Partial Nephrectomy in Renal Cell Carcinoma 28 April, 2017 Friday 13:40 14:00 Treatment of Locally-Advanced Renal Cancer Vsevolod Matveev 14:00 15:00 Session 3: Bladder cancer and Miscellaneous 14:00 14:20 Non Muscle Invasive Bladder Cancer: Current Issues Oleg Karyakin 14:20 14:35 How to Improve Transurethral Resection of Bladder Tumors: En-bloc Resection Igor Masansky 14:35 15:00 Quality of Life outcomes for Radical Cystectomy with Ileal Conduit, Indiana Pouch, and Neobladder 15:00 15:30 Coffee break 15:30 15:50 Neoadjuvant and Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer 15:50 16:20 Ensuring Surgical Safety and Quality Kathleen Schmeler 16:20 16:40 M&M Conference Cases 16:40 17:00 Pharmacotherapy of Chronic Oncologic Pain Averchenko Tatiana 3/5

in Gynecologic and Oncology Day 3 29 April, 2017 Saturday 9:00 11:00 Diagnosis and treatment of testicular cancer 9:00 9:05 Welcome Chairman: Sergey Krasny, Sergey Krasny, 9:05 9:20 Setting the Stage: Epidemiology and Current Status of Testicular Cancer in Belarus Alesia Evmenenko 9:20 9:35 Epidemiology of Testicular Cancer and Risk Factors: Global Perspective Avi Bery 9:35 10:35 Contemporary Management of Testis Cancer: 10:35 10:45 Q&A 10:45 11:00 Quality Improvement in Testicular Cancer Management in Belarus 11:00 12:00 Masterclass on Testicular Cancer with Case Discussion (Part 1) Faculty:,, Vsevolod Matveev, Eduard Zhavrid, Sergey Рolyakov, Sophia Michaelson 11:00 11:15 11:15 11:25 Diagnosis and Staging Clinical Cases/Discussion Sergey Polyakov 11:25 11:40 Biology and Pathology of Germ-Cell Testicular Neoplasia Tatiana Nabebina 11:40 11:55 Biomarkers in Germ Cell Tumors Alena Suboch 11:55 12:00 Q&A 4/5

in Gynecologic and Oncology Day 3 13:00 17:00 Masterclass on Testicular Cancer with Case Discussion (Part 2) 13:00 13:20 13:20 13:30 Management of NSGCT Clinical Stage I 29 April, 2017 Saturday 13:30 13:45 13:45 13:55 13:55 14:10 14:10 14:20 14:20 14:35 14:35 14:45 Management of Seminoma Metastatic Germ Cell Tumors Management of Good Prognosis Risk Group Tatiana Ivanitskaya Metastatic Germ Cell Tumors. Initial Management of Intermediate and Poor Prognosis Risk Group Nikolay Ermakov, Olga Kalenik 14:45 15:15 Coffee break 15:15 15:35 15:35 15:45 15:45 16:05 16:05 16:15 16:15 16:35 16:35 16:45 The Role of Restaging and Residual Tumor Resection Vsevolod Matveev Postchemotherapy Surgery: Advanced Cases Management of Relapses and Refractory Disease 16:45 17:00 Treatment of Complications and Late Sequelae 17:00 17:10 Closing remarks, Sergey Polyakov 5/5